PWS
AZN icon

Precision Wealth Strategies’s AstraZeneca AZN Stock Holding History

Precision Wealth Strategies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233K Sell
1,179
-9
-0.8% -$1.74K 0.08% 150
2025
Q4 		$218K Buy
+1,188
New +$208K 0.07% 152

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Precision Wealth Strategies's AZN Position: Q1 2026 in Review

Precision Wealth Strategies reduced its AstraZeneca (AZN) stake by 0.76% in Q1 2026, selling an estimated $1.74K and leaving 1,179 shares worth $233K. The position accounts for 0.08% of the portfolio, ranked #150.

Precision Wealth Strategies first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Precision Wealth Strategies held 1,179 shares of AstraZeneca worth $233K as of Q1 2026.
  • Precision Wealth Strategies sold 9 AstraZeneca shares in Q1 2026, an estimated $1.74K.
  • AstraZeneca made up 0.08% of Precision Wealth Strategies's portfolio in Q1 2026, its #150 holding.
  • Precision Wealth Strategies first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Precision Wealth Strategies's 13F filing for Q1 2026, filed 6 May 2026.